Kaleido BioSciences Stock

Kaleido BioSciences is a company working to design and analyze the microbiome system and provide adaptive solutions.

About Kaleido BioSciences Stock

Tremendous new therapeutic opportunities are emerging from our rapidly expanding knowledge of the human microbiome. Kaleido is exploring this newfound territory through a unique discovery platform that develops novel chemistries targeted at specific microbiome functions. Our approach has produced clinically supported leads in multiple disease areas.

Funding History

August 2015	$4.5M
September 2017	$60.0M
June 2018	$101M

Press

Bedford Startup Kaleido Biosciences Raises $101 Million in Funding Round

The Boston Globe - Jun, 25 2018

Kaleido Biosciences Announces Appointments to Leadership Team

Business Wire - Mar, 26 2018

Kaleido Biosciences Expands Leadership Team with Appointment of Alison Lawton as President and Chief Operating Officer

Business Wire - Dec, 12 2017

Other Companies

Compass Therapeutics is a biopharmaceutical company focused on drugging the immune system to treat human diseases.

Drug discovery company

6Age (years)

$156MTotal Funding

Learn More

Theragene Pharmaceuticals

Theragene Pharmaceuticals combines innovative science and efficiency to develop life-saving therapies for many debilitating diseases.

Whole Biome is a microbiome company focused on enabling better patient care through targeted equilibration of human microbiomes.

6Age (years)

$35.0MTotal Funding

EquityZen does not have an affiliation with, formal relationship with, or endorsement from Kaleido BioSciences or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.

Some data provided by Crunchbase

Trending Companies

Join 190K+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As:

Why EquityZen?

EquityZen helps investors to access private companies and their employees to sell shares.

Investment opportunities posted on this website are "private placements" of securities that are not publicly traded, are subject to holding period requirements, and are intended for investors who do not need a liquid investment. Investing in private companies may be considered highly speculative and involves a high degree of risk, including the risk of substantial loss of investment. Investors must be able to afford the loss of their entire investment. See our Risk Factors for a more detailed explanation of the risks involved by investing through EquityZen’s platform.

EquityZen Securities LLC (“EquityZen Securities”) is a subsidiary of EquityZen Inc. EquityZen Securities is a broker/dealer registered with the Securities Exchange Commission and is a FINRA/SIPC member firm.

Equity securities are offered through EquityZen Securities. Check the background of this firm on FINRA’s BrokerCheck.

EquityZen.com is a website operated by EquityZen Inc. ("EquityZen"). By accessing this site and any pages thereof, you agree to be bound by our Terms of Use.
EquityZen and logo are trademarks of EquityZen Inc. Other trademarks are property of their respective owners.
© 2020 EquityZen Inc. All rights reserved.